Bodycote PLC Stock Reacts to Apollo Withdrawal of Takeover Bid
Bodycote PLC (BOY), a London‑listed provider of heat‑treatment and metallurgical services, saw its share price fall sharply after United States private‑equity group Apollo Global Management announced that it would no longer pursue a takeover offer. The announcement came on 5 June 2026, after Apollo had previously indicated a £1.5 billion (approximately $2 billion) bid.
Immediate Market Impact
- The stock dropped 9.4 % early in the trading day, with the share price falling from around £8.30 to £7.60.
- Trading volume spiked to more than twice the average daily volume, reflecting a surge in investor interest following the news.
- The decline pushed the 52‑week high of £8.50 lower and tightened the band between the 52‑week low of £5.485 and the current price.
Apollo’s Decision
Apollo cited an increased perception of fraud risk in the mergers and acquisitions market, as reported by Aon, as a factor in its decision to withdraw the bid. The firm’s withdrawal was communicated through a formal statement and a press release, confirming that it would not make a formal offer for Bodycote. Under the UK takeover code, this limits Apollo from making another offer for the company for a specified period.
Bodycote’s Response
Bodycote’s board reiterated confidence in the company’s strategy and long‑term growth prospects. The company emphasized that its core operations—metal technology, isostatic pressings, and metallurgical coatings—remain robust and that the withdrawal does not affect its business plan or financial outlook.
Sector and Market Context
The industrials and machinery sector was largely flat on the day, with minor movements in related stocks. Bodycote’s market capitalisation stood at £1.879 billion, with a price‑to‑earnings ratio of 26.42. The company’s share performance has been influenced by broader market dynamics, including European equity movements and expectations for U.S. employment data later in the week.
Outlook
With the takeover attempt off the table, Bodycote’s immediate focus will remain on its operational expansion and service delivery. Investors will likely monitor any future developments in the M&A landscape that could affect the company’s valuation.




